120 related articles for article (PubMed ID: 3517890)
1. Contribution to the search for vigilance-indicative EEG variables. Results of a controlled, double-blind study with pyritinol in elderly patients with symptoms of mental dysfunction.
Herrmann WM; Kern U; Röhmel J
Pharmacopsychiatry; 1986 Mar; 19(2):75-83. PubMed ID: 3517890
[TBL] [Abstract][Full Text] [Related]
2. On the effects of pyritinol on functional deficits of patients with organic mental disorders.
Herrmann WM; Kern U; Röhmel J
Pharmacopsychiatry; 1986 Sep; 19(5):378-85. PubMed ID: 3534901
[TBL] [Abstract][Full Text] [Related]
3. [Demonstration of bencyclane effects in a clinico-pharmacologic vigilance model].
Herrmann WM; Kern U
Z Gerontol; 1984; 17(5):261-70. PubMed ID: 6395526
[TBL] [Abstract][Full Text] [Related]
4. Accelerated remission of the alcoholic organic brain syndrome with EMD 21657. Double-blind clinical and psychometric trials.
Saletu M; Grünberger J; Saletu B; Mader R
Arzneimittelforschung; 1978; 28(9):1525-7. PubMed ID: 383103
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled study of pyritinol ('Encephabol') in dementia.
Cooper AJ; Magnus RV
Pharmatherapeutica; 1980; 2(5):317-22. PubMed ID: 7001490
[TBL] [Abstract][Full Text] [Related]
6. [Pyrithioxin (Encephabol) in the treatment of patients with organic psychosyndrom in involution. Clinical, EEG and experimental psychological study (author's transl)].
Misurec J; Sláma B; Náhunek K
Cesk Psychiatr; 1976 Feb; 72(1):14-23. PubMed ID: 773551
[No Abstract] [Full Text] [Related]
7. [The effect of Ginkgo biloba extract on neurophysiological and psychometric measurement results in patients with psychotic organic brain syndrome. A double-blind study against placebo].
Hofferberth B
Arzneimittelforschung; 1989 Aug; 39(8):918-22. PubMed ID: 2684175
[TBL] [Abstract][Full Text] [Related]
8. Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements.
Knezevic S; Mubrin Z; Risberg J; Vucinic G; Spilich G; Gubarev N; Wannenmacher W
Int Clin Psychopharmacol; 1989 Jan; 4(1):25-38. PubMed ID: 2687355
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
[TBL] [Abstract][Full Text] [Related]
10. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
Herrmann WM; Schärer E; Wendt G; Delini-Stula A
Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
[TBL] [Abstract][Full Text] [Related]
11. [Microsleep from the electro- and psychophysiological point of view].
Faber J; Novák M; Svoboda P; Tatarinov V; Tichý T
Sb Lek; 2003; 104(4):375-85. PubMed ID: 15320529
[TBL] [Abstract][Full Text] [Related]
12. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
[TBL] [Abstract][Full Text] [Related]
13. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experience with Encephabol (author's transl)].
Glatzel J
Med Klin; 1976 Nov; 71(45):1958-61. PubMed ID: 792665
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
[TBL] [Abstract][Full Text] [Related]
16. Interaction of changes in hospital environment and neurotropic co-medication in chronic psychiatric inpatient. A placebo controlled double-blind study.
Lehmann E; Kretschmar JH; Brauer H; Reinhardt B
Pharmacopsychiatria; 1982 Mar; 15(2):57-60. PubMed ID: 7043497
[TBL] [Abstract][Full Text] [Related]
17. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
Baro F; Malfroid M; Waegemans T; Cox JP
Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of pyritinol on sequelae of head injuries.
Kitamura K
J Int Med Res; 1981; 9(3):215-21. PubMed ID: 7016627
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
Otomo E; Araki G; Mori A; Kurihara M
Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354
[TBL] [Abstract][Full Text] [Related]
20. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
